3月龄颅脑MRI在围产期窒息后新生儿脑病中的附加价值
这项回顾性单中心研究纳入63例围产期窒息合并新生儿脑病(NE)的婴儿(其中28例接受低温治疗),在出生后<2周和2-4个月分别进行颅脑MRI。研究评估脑损伤演变,并开发3月龄MRI评分,分析其与18-24月龄复合不良结局的关联。结果显示3月龄深部灰质(DGM)评分(OR 1.5,95%CI 1.2-2.0)和白质(WM)评分(OR 1.1,95%CI 1.0-1.3)与复合不良结局相关;3月龄多变量模型阳性预测值高于新生儿MRI(0.88 vs 0.83),但阴性预测值较低(0.83 vs 0.84)。
要点
- 3月龄DGM评分与18-24月龄复合不良结局独立相关(OR 1.5,95%CI 1.2-2.0)。
- 3月龄MRI多变量模型阳性预测值0.88,高于新生儿MRI的0.83。
- 3月龄MRI临床实用性相比新生儿MRI似乎有限。
核心结论
- 3月龄MRI的DGM异常(先前存在新生儿MRI的DGM异常)与18-24月龄结局相关,提示3月龄MRI可用于神经保护试验的疗效评估。
- 但相较于新生儿MRI,3月龄MRI的临床实用性似乎有限。
研究设计与样本
- 回顾性单中心研究,纳入63例围产期窒息合并NE的婴儿(n=28接受低温治疗),均于出生后<2周及2-4个月接受颅脑MRI。
- 两次扫描均采用生物测量、验证过的新生儿MRI损伤评分及新开发的3月龄MRI评分(含WM、DGM和小脑子评分)进行评估。
- 评估脑病变演变,并将两次扫描与18-24月龄复合结局相关联;不良结局包括脑瘫、神经发育迟缓、听力/视力障碍和癫痫。
主要发现
- 新生儿DGM损伤一般演变为DGM萎缩和局灶性信号异常,WM/分水岭损伤演变为WM和/或皮质萎缩。
- 复合不良结局发生于n=23;3月龄DGM评分(OR 1.5,95%CI 1.2-2.0)和WM评分(OR 1.1,95%CI 1.0-1.3)与复合不良结局相关。
- 3月龄多变量模型(含DGM和WM子评分)的阳性预测值为0.88(新生儿MRI为0.83),阴性预测值为0.83(新生儿MRI为0.84)。
- 3月龄总分、WM和DGM评分的评分者间一致性分别为0.93、0.86和0.59。
关键数值与推荐
- 3月龄DGM评分OR 1.5(95%CI 1.2-2.0),WM评分OR 1.1(95%CI 1.0-1.3),均与复合不良结局相关。
- 3月龄多变量模型阳性预测值0.88 vs 新生儿MRI 0.83;阴性预测值0.83 vs 0.84。
- 评分者间一致性:总分0.93,WM 0.86,DGM 0.59。
临床怎么用
- 3月龄MRI的DGM异常可辅助评估围产期窒息后NE婴儿的远期神经发育结局,尤其适用于神经保护治疗的疗效评价。
- 鉴于其临床实用性相较新生儿MRI有限,3月龄MRI不应常规替代新生儿MRI,但可作为补充信息。
局限性
- 回顾性单中心设计,样本量63例,其中仅28例接受低温治疗,可能存在选择偏倚。
- 3月龄DGM评分的评分者间一致性为0.59,提示该子评分可靠性中等。
- 3月龄MRI的阴性预测值略低于新生儿MRI(0.83 vs 0.84),可能影响其排除不良结局的能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the evolution of neonatal brain injury noted on magnetic resonance imaging (MRI), develop a score to assess brain injury on 3-month MRI, and determine the association of 3-month MRI with neurodevelopmental outcome in neonatal encephalopathy (NE) following perinatal asphyxia. METHODS: This was a retrospective, single-center study including 63 infants with perinatal asphyxia and NE (n = 28 cooled) with cranial MRI <2 weeks and 2-4 months after birth. Both scans were assessed using biometrics, a validated injury score for neonatal MRI, and a new score for 3-month MRI, with a white matter (WM), deep gray matter (DGM), and cerebellum subscore. The evolution of brain lesions was assessed, and both scans were related to 18- to 24-month composite outcome. Adverse outcome included cerebral palsy, neurodevelopmental delay, hearing/visual impairment, and epilepsy. RESULTS: Neonatal DGM injury generally evolved into DGM atrophy and focal signal abnormalities, and WM/watershed injury evolved into WM and/or cortical atrophy. Although the neonatal total and DGM scores were associated with composite adverse outcomes, the 3-month DGM score (OR 1.5, 95% CI 1.2-2.0) and WM score (OR 1.1, 95% CI 1.0-1.3) also were associated with composite adverse outcomes (occurring in n = 23). The 3-month multivariable model (including the DGM and WM subscores) had higher positive (0.88 vs 0.83) but lower negative predictive value (0.83 vs 0.84) than neonatal MRI. Inter-rater agreement for the total, WM, and DGM 3-month score was 0.93, 0.86, and 0.59. CONCLUSIONS: In particular, DGM abnormalities on 3-month MRI, preceded by DGM abnormalities on the neonatal MRI, were associated with 18- to 24-month outcome, indicating the utility of 3-month MRI for treatment evaluation in neuroprotective trials. However, the clinical usefulness of 3-month MRI seems limited compared with neonatal MRI.
引用
- Parmentier CEJ, Lequin MH, Alderliesten T, et al. Additional Value of 3-Month Cranial Magnetic Resonance Imaging in Infants with Neonatal Encephalopathy following Perinatal Asphyxia. J Pediatr. 2023. PMID: 37019329. doi:10.1016/j.jpeds.2023.113402
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。